Optum Rx is moving to eliminate prior authorizations on dozens of drugs, the UnitedHealth-owned pharmacy benefit manager said Wednesday, paring back a key pain point for physicians and ...

The pharmacy benefit manager has removed reauthorization requirements for more than 140 drugs so far this year amid what ...

Perry Cohen, Pharm.D., a longtime member of the Managed Healthcare Executive editorial advisory board, is host of the ...

UnitedHealth Group’s Optum Rx will remove reauthorization requirements for more than 60 chronic disease medications on July 1.  The cuts are in addition to about 80 reauthorizations Optum Rx ...

The massive PBM is pivoting to a cost-based reimbursement model, which it says will reduce variation in how pharmacies are paid. Pharmacy groups say that depends on the specifics of Optum Rx’s plan.

UNH expects Optum Rx’s revenues to be between $145.5 billion and $146.5 billion for 2025, and its long-term growth rate to be 5-8%. Shares of UnitedHealth Group have gained 4% in the past year ...

Optum Rx, a subsidiary of UnitedHealth Group, on Friday filed a motion to dismiss the lawsuit brought by the family of Cole Schmidtknecht. News Sports Packers Business Go 920!

A Wisconsin couple are suing Walgreens and Optum Rx over their son's death, claiming he was unable to afford a sudden spike of cost in his asthma medication.

Optum Rx is nixing reauthorization requirements for more than 60 additional medications. | The PBM giant's list of drugs includes products for behavioral health, HIV, dry eye disease, high cholesterol ...

Optum Rx officials said they now have eliminated reauthorization requirements for more than 140 chronic disease medications.

The company is adding new products treating a range of issues, including HIV, hypertension and behavioral health.